Bone Biologics Enters Into Definitive Agreement for $3.0M Private Plac

Bone Biologics enters into definitive agreement for $3.0M private plac

Bone Biologics Corporation (BBLG) announced it has entered into a definitive agreement with a single healthcare-focused institutional investor for an at-the-market private placement expected to yield $3.0M in initial gross proceeds.

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash BURLINGTON, Mass., July 07, 2026...